Dr. Carol Wilkinson, MD PhD, and Dr. Charles Nelson, PhD, at Boston Children’s Hospital are recruiting children ages 2-7 years with Fragile X syndrome to participate in a study of brain differences using non-invasive EEG.
Read moreBoston Children’s Hospital
Neural Markers of Fragile X: A Powerful New Tool for Clinical Trials
![Neural Markers of Fragile X: A Powerful New Tool for Clinical Trials Neural Markers of Fragile X: A Powerful New Tool for Clinical Trials](https://www.fraxa.org/wp-content/uploads/2017/08/EEG-NeuralMarker-720x300.jpg)
Once the neural marker is identified for a particular challenge, such as kids with poor language versus good language, neural markers can be measured during drug and behavioral therapy trials to see if a child is improving based on objective biological measures.
Read more